- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous ex-rep alleged off-licence promotion of Naloxone Minijet. Panel found no off-licence breach, but ruled an internal conference poster functioned as rep…
MSD sent a third-party email invite (via Pulse) to a cardiovascular webcast labelled promotional but with no product named and no prescribing…
A competitor challenged a Salofalk Granules journal ad. The PMCPA ruled the “step change… Now that’s progress” headline misleading, exaggerated and unsubstantiated…
Toujeo iPad “Latest Data” app design and training encouraged linking clamp-study PK/PD variability data to reduced hypoglycaemia. Panel found the material misleading…
A health professional alleged a Morphgesic SR ad used outdated prescribing information (May 2013). The Panel found the PI had a Dec…
Guardian articles criticised Gardasil promotion and a Paris cervical cancer summit. Panel found breaches for inadequate upfront sponsorship disclosure on invitations and…
A Levemir journal ad showing overweight women in a pool with the strapline “Levemir is changing figures” was ruled misleading/ambiguous, implying weight…
Anonymous complaint about AstraZeneca-sponsored psychiatrist meetings. Panel upheld one breach: overnight accommodation for a 4.5-hour Coventry meeting was not justified (Clause 19.1).…
A PCT adviser challenged AstraZeneca’s Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found the audience and hospitality…
A sponsored athlete with diabetes spoke to parents at a hospital fun day and repeatedly praised Lantus. PMCPA held Sanofi-Aventis responsible and…
A hospital pharmacist complained about a Pliva email to a colleague chasing action after a discounts/generics meeting. Panel found Cystistat was a…
GPs alleged a professor’s mesalazine letter (P&G educational grant) was disguised promotion for Asacol. Panel found no promotion/disguised promotion, but ruled Clause…
A Tramacet e-ad compared NNTs but omitted the commonly used co-codamol 60/1000 NNT (2.2), making Tramacet look more favourable. Breach of Clauses…
PMCPA case AUTH/3006/12/17 (Director v Lilly) concerning clinical trial disclosure for Trulicity. Outcome: No breach; matter was outwith the scope of the…
At ESC Congress 2015, Mylan offered frozen yoghurt from its exhibition stand. The Panel ruled this went beyond subsistence hospitality (Clause 22.1)…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.